Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development

Abstract

The blood‐brain barrier (BBB) is a highly controlled microenvironment that regulates the interactions between cerebral blood and brain tissue. Due to its selectivity, many therapeutics targeting various neurological disorders have not been able to penetrate brain tissue. Pre‐clinical studies using animals and other in vitro platforms have not shown the ability to fully replicate the human BBB leading to the failure of a majority of therapeutics in clinical trials. However, recent innovations in vitro and ex vivo modeling called Organs‐on‐chips have shown the potential to create more accurate disease models for improved drug development. These microfluidic platforms induce physiological stressors on cultured cells and have been able to generate more physiologically accurate BBBs compared to previous in vitro models. In this review, different approaches to creating BBBs‐on‐chips are explored alongside their application in modeling various neurological disorders and potential therapeutic efficacy. Additionally, organs‐on‐chips use in BBB drug delivery studies is discussed, and advances in linking brain organs‐on‐chips onto multiorgan platforms to mimic organ crosstalk are reviewed.This article is protected by copyright. All rights reserved